Analysis of the therapeutic benefits of symptomatic slow acting drugs in osteoarthritis: emphasis on structural-modifying action
The review presents an analysis of the therapeutic effect in osteoarthritis (OA) of the original complex injectable drug Alflutop (bioactive concentrate of small marine fish), which is one of the most widely used symptomatic slow acting drugs (SYSADOA) in Russia. It stimulates the proliferation of c...
Main Authors: | I. B. Belyaeva, V. I. Mazurov, E. A. Trofimov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1239 |
Similar Items
-
An open prospective study of the efficacy and safety of therapy with a bioactive concentrate of small marine fish in patients with vertebrogenic lumboischialgia
by: F. A. Khabirov, et al.
Published: (2022-06-01) -
Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
by: I. B. Belyaeva, et al.
Published: (2022-08-01) -
Analysis of safety of bioactive concentrate of small sea fish therapy in comorbid patients with osteoarthritis
by: O. V. Zimnitskaya, et al.
Published: (2021-06-01) -
Chronic back pain as a spinal osteoarthritis manifestation: rationale and practice of symptomatic slow acting drugs for osteoarthritis use
by: A. E. Karateev
Published: (2022-08-01) -
Therapeutic potential of a drug based on avocado and soy unsaponifiable compounds in the treatment of osteoarthritis: data from Russian and international studies (descriptive review)
by: A. E. Karateev, et al.
Published: (2022-05-01)